Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,241 to 1,260 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. | Oncotarget | 2020 | 32082487 | PubTator, text mining | PubMed |
| A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present). | Expert Opin Ther Pat | 2020 | 32077340 | PubTator, text mining | PubMed |
| Biphasic Mathematical Model of Cell-Drug Interaction That Separates Target-Specific and Off-Target Inhibition and Suggests Potent Targeted Drug Combinations for Multi-Driver Colorectal Cancer Cells. | Cancers (Basel) | 2020 | 32069833 | PubTator, text mining | PubMed |
| Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation. | J Clin Med | 2020 | 32050484 | PubTator, text mining | PubMed |
| Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts. | Sci Rep | 2020 | 32047176 | PubTator, text mining | PubMed |
| Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma. | Cancers (Basel) | 2020 | 32046309 | PubTator, text mining | PubMed |
| Neurology-related protein biomarkers are associated with cognitive ability and brain volume in older age. | Nat Commun | 2020 | 32041957 | PubTator, text mining | PubMed |
| Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion. | Adv Exp Med Biol | 2020 | 32034713 | PubTator, text mining | PubMed |
| Identifying the key genes and microRNAs in prostate cancer bone metastasis by bioinformatics analysis. | FEBS Open Bio | 2020 | 32027093 | PubTator, text mining | PubMed |
| Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome. | Cancers (Basel) | 2020 | 32024067 | PubTator, text mining | PubMed |
| Exosomal Long Non-Coding RNA Expression from Serum of Patients with Acute Minor Stroke. | Neuropsychiatr Dis Treat | 2020 | 32021207 | PubTator, text mining | PubMed |
| The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt. | Diagn Pathol | 2020 | 32019558 | PubTator, text mining | PubMed |
| From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer. | Cells | 2020 | 32012917 | PubTator, text mining | PubMed |
| MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions. | Noncoding RNA Res | 2020 | 31993547 | PubTator, text mining | PubMed |
| PGC1α suppresses kidney cancer progression by inhibiting collagen-induced SNAIL expression. | Matrix Biol | 2020 | 31982456 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis. | Cell Commun Signal | 2020 | 31980029 | PubTator, text mining | PubMed |
| Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity. | Molecules | 2020 | 31979355 | PubTator, text mining | PubMed |
Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology. | Int J Clin Oncol | 2020 | 31974683 | PubTator, text mining | PubMed |
| Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis. | World J Surg Oncol | 2020 | 31959178 | PubTator, text mining | PubMed |
| Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy. | ACS Med Chem Lett | 2020 | 31938459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=63